Access the full text.
Sign up today, get DeepDyve free for 14 days.
P. Ganz (2010)
Quality-of-life issues in patients with ductal carcinoma in situ.Journal of the National Cancer Institute. Monographs, 2010 41
W Hindle (1999)
10.1007/978-1-4612-2144-9Breast Care: A Clinical Guidebook for Women’s Primary Health Care Providers
Shi-zheng Li, Song Yuan, Qian Zhao, Bo Wang, Xiuyan Wang, Kun-Sheng Li (2018)
Quercetin enhances chemotherapeutic effect of doxorubicin against human breast cancer cells while reducing toxic side effects of it.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 100
Anthony Miller, Molly Black, Jaume Amengual (2021)
Fenretinide inhibits vitamin A formation from β-carotene and regulates carotenoid levels in mice.Biochimica et biophysica acta. Molecular and cell biology of lipids
A. Acibuca, A. Sezer, Mustafa Yilmaz, A. Sumbul, Ş. Demircan, I. Muderrisoglu, O. Ozyılkan (2021)
Cardiotoxicity of trastuzumab emtansine (T-DM1): a single-center experienceThe Journal of International Medical Research, 49
R. Chlebowski, G. Anderson, M. Gass, D. Lane, A. Aragaki, L. Kuller, J. Manson, M. Stefanick, J. Ockene, G. Sarto, K. Johnson, J. Wactawski‐Wende, P. Ravdin, R. Schenken, S. Hendrix, A. Rajkovic, T. Rohan, S. Yasmeen, R. Prentice (2010)
Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women.JAMA, 304 15
Rondi Kauffmann, L. Goldstein, Emily Marcinkowski, G. Somlo, Yuan Yuan, P. Ituarte, L. Kruper, L. Taylor, C. Vito (2016)
Predictors of Antiestrogen Recommendation in Women With Estrogen Receptor-Positive Ductal Carcinoma In Situ.Journal of the National Comprehensive Cancer Network : JNCCN, 14 9
V. Sacchini, L. Fortunato, H. III, K. Zee, B. Cutuli, B. Bonanni (2012)
Breast Ductal Carcinoma In SituInternational Journal of Surgical Oncology, 2012
A. McKay, S. Latosinsky, W. Martin (2005)
Acceptance of tamoxifen chemoprevention by physicians and women at riskCancer, 103
B. Reddy, R. Banerjee (2005)
17β‐Estradiol‐Associated Stealth‐Liposomal Delivery of Anticancer Gene to Breast Cancer CellsAngewandte Chemie, 44
Xinyi Gao, M. Patel, Pooja Bakshi, D. Sharma, A. Banga (2018)
Enhancement in the Transdermal and Localized Delivery of Honokiol Through Breast TissueAAPS PharmSciTech, 19
J. Melnikow, D. Paterniti, R. Azari, C. Kuenneth, S. Birch, M. Kuppermann, J. Nuovo, J. Keyzer, Stuart Henderson (2005)
Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reductionCancer, 103
BS Reddy, R Banerjee (2005)
17β-estradiol-associated stealth-liposomal delivery of anticancer gene to breast cancer cellsAngew Chem, 117
Ankita Gupta, G. Aggarwal, Samita Singla, R. Arora (2012)
Transfersomes: A Novel Vesicular Carrier for Enhanced Transdermal Delivery of Sertraline: Development, Characterization, and Performance EvaluationScientia Pharmaceutica, 80
Kalvatala Sudhakar, S. Fuloria, V. Subramaniyan, K. Sathasivam, A. Azad, S. Swain, M. Sekar, S. Karupiah, O. Porwal, Alaka Sahoo, D. Meenakshi, V. Sharma, S. Jain, R. Charyulu, N. Fuloria (2021)
Ultraflexible Liposome Nanocargo as a Dermal and Transdermal Drug Delivery SystemNanomaterials, 11
A. Lila, M. Soliman, H. Kiran, H. Gangadharappa, K. Younes, El-Sayed Khafagy, Tamer Shehata, M. Ibrahim, M. Abdallah (2021)
Tamoxifen-loaded functionalized graphene nanoribbons for breast cancer therapyJournal of Drug Delivery Science and Technology, 63
Firas Al-Zubaydi, Dayuan Gao, Dipti Kakkar, Shike Li, Derek Adler, Jennifer Holloway, Z. Székely, Zichao Gu, N. Chan, Shicha Kumar, S. Love, P. Sinko (2020)
Breast intraductal nanoformulations for treating ductal carcinoma in situ I: Exploring metal-ion complexation to slow ciclopirox release, enhance mammary persistence and efficacy.Journal of controlled release : official journal of the Controlled Release Society
Rammohan Devulapally, T. Sekar, R. Paulmurugan (2015)
Formulation of Anti-miR-21 and 4-Hydroxytamoxifen Co-loaded Biodegradable Polymer Nanoparticles and Their Antiproliferative Effect on Breast Cancer CellsMolecular Pharmaceutics, 12
S. Jain, P. Jain, R. Umamaheshwari, N. Jain (2003)
Transfersomes—A Novel Vesicular Carrier for Enhanced Transdermal Delivery: Development, Characterization, and Performance EvaluationDrug Development and Industrial Pharmacy, 29
Srivarsha Bollareddy, Vandana Krishna, G. Roy, D. Dasari, A. Dhar, V. Venuganti (2022)
Transfersome Hydrogel Containing 5-Fluorouracil and Etodolac Combination for Synergistic Oral Cancer TreatmentAAPS PharmSciTech, 23
Abeer Khamis, E. Ali, M. El-Moneim, M. Abd-Alhaseeb, M. El-Magd, E. Salim (2018)
Hesperidin, piperine and bee venom synergistically potentiate the anticancer effect of tamoxifen against breast cancer cells.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 105
Usha Sundralingam, S. Chakravarthi, A. Radhakrishnan, Saravanan Muniyandy, U. Palanisamy (2020)
Efficacy of Emu Oil Transfersomes for Local Transdermal Delivery of 4-OH Tamoxifen in the Treatment of Breast CancerPharmaceutics, 12
A. Schneeweiss, S. Chia, T. Hickish, Vernon Harvey, A. Eniu, R. Hegg, C. Tausch, J. Seo, Y. Tsai, J. Ratnayake, V. Mcnally, G. Ross, J. Cortés (2013)
Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA).Annals of oncology : official journal of the European Society for Medical Oncology, 24 9
Schwab Roxana, Boutas Ioannis, Dappa Evelyn, Kohlwes Elke, B. Michaela, Woll Joerg, Potiris Anastasios, Künzel Klaudija, Hasenburg Annette (2020)
Polypoid Endometriosis in A Postmenopausal Woman Treated With Tamoxifen Due to DCIS: A Case Report And Review of the LiteratureClinical & Biomedical Research, 4
Carol Fabian, Lowell Tilzer, L. Sternson (1981)
Comparative binding affinities of tamoxifen, 4-hydroxytamoxifen, and desmethyltamoxifen for estrogen receptors isolated from human breast carcinoma: correlation with blood levels in patients with metastatic breast cancer.Biopharmaceutics & drug disposition, 2 4
Mohamed Elshal, Norhan Eid, I. El-Sayed, W. El-Sayed, A. Al-karmalawy (2021)
Concanavalin-A shows synergistic cytotoxicity with tamoxifen via inducing apoptosis in estrogen receptor-positive breast cancer: In vitro and molecular docking studiesPharmaceutical Sciences
Ehsan Nankali, M. Shaabanzadeh, M. Torbati (2020)
Fluorescent tamoxifen-encapsulated nanocapsules functionalized with folic acid for enhanced drug delivery toward breast cancer cell line MCF-7 and cancer cell imagingNaunyn-Schmiedeberg's Archives of Pharmacology, 393
C. Kim, Sang Lee, M. Kang, Sangkil Lee, Y. Choi (2017)
Surface modification of lipid-based nanocarriers for cancer cell-specific drug targetingJournal of Pharmaceutical Investigation, 47
Radwa Radwan, Ayat Abdelkader, Heba Fathi, Mahmoud Elsabahy, G. Fetih, M. El-Badry (2021)
Development and Evaluation of Letrozole-Loaded Hyaluronic Acid/Chitosan-Coated Poly(d,l-lactide-co-glycolide) NanoparticlesJournal of Pharmaceutical Innovation, 17
Raju Vivek, V. Babu, R. Thangam, R. Thangam, Kizhaeral Subramanian, Soundarapandian Kannan (2013)
pH-responsive drug delivery of chitosan nanoparticles as Tamoxifen carriers for effective anti-tumor activity in breast cancer cells.Colloids and surfaces. B, Biointerfaces, 111
Anja Gronewold, M. Horn, Ivan Ranđelović, J. Tóvári, Sergio Muñoz Vázquez, K. Schomäcker, I. Neundorf (2016)
Characterization of a Cell‐Penetrating Peptide with Potential Anticancer ActivityChemmedchem, 12
Joan Lewis, V. Jordan (2005)
Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance.Mutation research, 591 1-2
E. Port, L. Montgomery, A. Heerdt, P. Borgen (2001)
Patient Reluctance Toward Tamoxifen Use for Breast Cancer Primary PreventionAnnals of Surgical Oncology, 8
Devika Nayak, Vamshi Tippavajhala (2021)
A Comprehensive Review on Preparation, Evaluation and Applications of Deformable LiposomesIranian Journal of Pharmaceutical Research : IJPR, 20
L. Solin, J. Kurtz, A. Fourquet, R. Amalric, A. Recht, B. Bornstein, R. Kuske, M. Taylor, W. Barrett, B. Fowble, B. Haffty, D. Schultz, I. Yeh, B. McCormick, M. Mcneese (1996)
Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 14 3
4-Hydroxytamoxifen or tamoxifen citrate in treating women with newly diagnosed ductal breast carcinoma in situ
S. Schnitt, W. Silen, N. Sadowsky, J. Connolly, J. Harris (1988)
Ductal carcinoma in situ (intraductal carcinoma) of the breast.The New England journal of medicine, 318 14
Md. Al-Bari (2020)
Co‐targeting of lysosome and mitophagy in cancer stem cells with chloroquine analogues and antibioticsJournal of Cellular and Molecular Medicine, 24
M. Seijen, E. Lips, A. Thompson, S. Nik-Zainal, A. Futreal, E. Hwang, E. Verschuur, J. Lane, J. Jonkers, D. Rea, J. Wesseling, J. Wesseling, Precision team (2019)
Ductal carcinoma in situ: to treat or not to treat, that is the questionBritish Journal of Cancer, 121
A. Partridge, K. Adloff, E. Blood, E. Dees, C. Kaelin, M. Golshan, J. Ligibel, Janet Moor, J. Weeks, K. Emmons, E. Winer (2008)
Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study.Journal of the National Cancer Institute, 100 4
A. Banga (2009)
Microporation applications for enhancing drug deliveryExpert Opinion on Drug Delivery, 6
Mahmoud Gharbavi, Behrooz Johari, Seyed Eslami, Navid Mousazadeh, A. Sharafi (2020)
Cholesterol‐conjugated bovine serum albumin nanoparticles as a tamoxifen tumor‐targeted delivery systemCell Biology International, 44
Samantha Kurtz, L. Lawson (2019)
Nanoemulsions Enhance in vitro Transpapillary Diffusion of Model Fluorescent Dye Nile RedScientific Reports, 9
Madhumita Royt, S. Mukherjee, Ruma Sarkar, J. Biswas (2011)
Curcumin sensitizes chemotherapeutic drugs via modulation of PKC, telomerase, NF-kappaB and HDAC in breast cancer.Therapeutic delivery, 2 10
B. Gulluoglu, S. Corradini (2010)
Breast CareBreast Care, 5
Phase I trial of endoxifen gel versus placebo in women undergoing breast surgery [ Internet ]
Suliman Khan, A. Hasan, F. Attar, Mohammad Babadaei, Hojjat Zeinabad, M. Salehi, M. Alizadeh, Mahbub Hassan, H. Derakhshankhah, Michael Hamblin, Qian Bai, M. Sharifi, M. Falahati, T. Hagen (2021)
Diagnostic and drug release systems based on microneedle arrays in breast cancer therapy.Journal of controlled release : official journal of the Controlled Release Society
O. Lee, D. Ivancic, R. Chatterton, A. Rademaker, S. Khan (2011)
In vitro human skin permeation of endoxifen: potential for local transdermal therapy for primary prevention and carcinoma in situ of the breast.Breast cancer, 3
Guannan Wang, Chuang Chen, P. Pai, P. Korangath, Shengrong Sun, V. Merino, Jingping Yuan, Suping Li, Guangjun Nie, V. Stearns, S. Sukumar (2019)
Intraductal fulvestrant for Therapy of ERα-positive Ductal Carcinoma in Situ (DCIS) of the breast- a Preclinical Study.Carcinogenesis
S. Abdel-Hafez, R. Hathout, O. Sammour (2018)
Curcumin-loaded ultradeformable nanovesicles as a potential delivery system for breast cancer therapy.Colloids and surfaces. B, Biointerfaces, 167
O. Lee, S. Khan (2016)
Novel routes for administering chemoprevention: local transdermal therapy to the breasts.Seminars in oncology, 43 1
Amar Patil, Roma Narvenker, B. Prabhakar, P. Shende (2020)
Strategic consideration for effective chemotherapeutic transportation via transpapillary route in breast cancer.International journal of pharmaceutics
Andrew Wang, R. Langer, O. Farokhzad (2012)
Nanoparticle delivery of cancer drugs.Annual review of medicine, 63
N. Olov, S. Bagheri‐Khoulenjani, H. Mirzadeh (2018)
Combinational drug delivery using nanocarriers for breast cancer treatments: A review.Journal of biomedical materials research. Part A, 106 8
O. Ibrahim, N. El-Deeb, H. Abbas, S. Elmasry, M. El-Aassar (2020)
Alginate based tamoxifen/metal dual core-folate decorated shell: Nanocomposite targeted therapy for breast cancer via ROS-driven NF-κB pathway modulation.International journal of biological macromolecules
R. Siegel, K. Miller, A. Jemal (2020)
Cancer statistics, 2020CA: A Cancer Journal for Clinicians, 70
O. Lee, K. Page, D. Ivancic, I. Helenowski, V. Parini, M. Sullivan, J. Margenthaler, R. Chatterton, B. Jovanovic, B. Dunn, B. Heckman-Stoddard, Kathleen Foster, M. Muzzio, Julia Shklovskaya, Silvia Skripkauskas, P. Kulesza, D. Green, N. Hansen, K. Bethke, J. Jeruss, R. Bergan, S. Khan (2014)
A Randomized Phase II Presurgical Trial of Transdermal 4-Hydroxytamoxifen Gel versus Oral Tamoxifen in Women with Ductal Carcinoma In Situ of the BreastClinical Cancer Research, 20
M. Mahoney, E. Gordon, J. Rao, Yusheng Jin, N. Hylton, S. Love (2013)
Intraductal therapy of ductal carcinoma in situ: a presurgery study.Clinical breast cancer, 13 4
Fariba Nokhodi, M. Nekoei, M. Goodarzi (2022)
Hyaluronic acid-coated chitosan nanoparticles as targeted-carrier of tamoxifen against MCF7 and TMX-resistant MCF7 cellsJournal of Materials Science. Materials in Medicine, 33
Xiaoyou Wang, Xianhui Chen, Xiucong Yang, Wei Gao, Bing He, Wenbing Dai, Hua Zhang, Xueqing Wang, Jiancheng Wang, Xuan Zhang, Z. Dai, Qiang Zhang (2016)
A nanomedicine based combination therapy based on QLPVM peptide functionalized liposomal tamoxifen and doxorubicin against Luminal A breast cancer.Nanomedicine : nanotechnology, biology, and medicine, 12 2
D. Fisher, I. Henderson, S. Schnitt, R. Christian, J. Harris (1993)
Chest wall recurrence of ductal carcinoma in situ of the breast after mastectomyCancer, 71
F. Malhão, A. Ramos, Ana Macedo, Eduardo Rocha (2021)
Cytotoxicity of Seaweed Compounds, Alone or Combined to Reference Drugs, against Breast Cell Lines Cultured in 2D and 3DToxics, 9
A. Zeb, O. Qureshi, Hyung-Seo Kim, Ji-Hye Cha, Hoo-Seong Kim, Jin-Ki Kim (2016)
Improved skin permeation of methotrexate via nanosized ultradeformable liposomesInternational Journal of Nanomedicine, 11
M. Singaraju, Subish Palaian, P. Shankar, S. Shrestha (2020)
Safety Profile and Toxicity Amelioration Strategies of Common Adverse Effects Associated with Anticancer MedicationsJournal of Pharmaceutical Research
(2018)
In vitro and in vivo biocompatibility study of folate-lysine-PEGPCL as nanocarrier for targeted breast cancer drug delivery
D. Guimarães, A. Cavaco‐Paulo, Eugénia Nogueira (2021)
Design of liposomes as drug delivery system for therapeutic applications.International journal of pharmaceutics
S. Johnston (2010)
New Strategies in Estrogen Receptor–Positive Breast CancerClinical Cancer Research, 16
D. Dershaw, A. Abramson, D Kinne (1989)
Ductal carcinoma in situ: mammographic findings and clinical implications.Radiology, 170 2
A pre-surgical PK study of IM and intraductally delivered fulvestrant -full text view -ClinicalTrials.gov
P. Garg, A. Jakhetiya, R. Pandey, N. Chishi, D. Pandey (2018)
Adjuvant radiotherapy versus observation following lumpectomy in ductal carcinoma in‐situ: A meta‐analysis of randomized controlled trialsThe Breast Journal, 24
N. Yaacob, N. Kamal, M. Norazmi (2014)
Synergistic anticancer effects of a bioactive subfraction of Strobilanthes crispus and tamoxifen on MCF-7 and MDA-MB-231 human breast cancer cell linesBMC Complementary and Alternative Medicine, 14
R. Clarke, Minetta Liu, K. Bouker, Zhiping Gu, Richard Lee, Yuelin Zhu, T. Skaar, Bianca Gomez, Kerry O'Brien, Yue Wang, L. Hilakivi-Clarke (2003)
Antiestrogen resistance in breast cancer and the role of estrogen receptor signalingOncogene, 22
G. Bhagwat, R. Athawale, Rajeev Gude, Shadab Md, N. Alhakamy, U. Fahmy, P. Kesharwani (2020)
Formulation and Development of Transferrin Targeted Solid Lipid Nanoparticles for Breast Cancer TherapyFrontiers in Pharmacology, 11
W. Hindle (2011)
Breast Care: A Clinical Guidebook for Women's Primary Health Care Providers
Pembrolizumab in high-risk ductal carcinoma in situ (DCIS) -full text view -ClinicalTrials.gov
A. Jain, Peeyush Goel, Sanket Shah, V. Dhawan, Yuvraj Nikam, R. Gude, M. Nagarsenker (2014)
Tamoxifen guided liposomes for targeting encapsulated anticancer agent to estrogen receptor positive breast cancer cells: in vitro and in vivo evaluation.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 68 4
N. Prathumsap, Krekwit Shinlapawittayatorn, S. Chattipakorn, N. Chattipakorn (2019)
Effects of doxorubicin on the heart: From molecular mechanisms to intervention strategies.European journal of pharmacology
Samantha Kurtz, L. Lawson (2019)
Liposomes Enhance Dye Localization within the Mammary Ducts of Porcine Nipples.Molecular pharmaceutics, 16 4
P. Ganz, R. Cecchini, T. Julian, R. Margolese, J. Costantino, L. Vallow, K. Albain, P. Whitworth, M. Cianfrocca, A. Brufsky, H. Gross, G. Soori, J. Hopkins, L. Fehrenbacher, Keren Sturtz, T. Wozniak, T. Seay, E. Mamounas, N. Wolmark (2016)
Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trialThe Lancet, 387
(2019)
Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One BreastCase Medical Research
L. Houdaihed, James Evans, C. Allen (2018)
Codelivery of Paclitaxel and Everolimus at the Optimal Synergistic Ratio: A Promising Solution for the Treatment of Breast Cancer.Molecular pharmaceutics, 15 9
Andrew Novick, Anthony Scott, C. Epperson, C. Schneck (2020)
Neuropsychiatric effects of tamoxifen: Challenges and opportunitiesFrontiers in Neuroendocrinology, 59
C. Stanciu-Pop, M. Nollevaux, M. Berlière, F. Duhoux, L. Fellah, C. Galant, M. Bockstal (2021)
Morphological intratumor heterogeneity in ductal carcinoma in situ of the breastVirchows Archiv, 479
Kaushalkumar Dave, Fahd Alsharif, S. Islam, C. Dwivedi, Omathanu Perumal (2017)
Chemoprevention of Breast Cancer by Transdermal Delivery of α-Santalol through Breast Skin and Mammary Papilla (Nipple)Pharmaceutical Research, 34
Mayuko Tsuda, Y. Takano, C. Shigeyasu, S. Imoto, M. Yamada (2016)
Abnormal Corneal Lesions Induced by Trastuzumab Emtansine: An Antibody–Drug Conjugate for Breast CancerCornea, 35
M. Silverstein, A. Barth, D. Poller, E. Gierson, W. Colburn, J. Waisman, P. Gamagami (1995)
Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast.European journal of cancer, 31A 9
Soo Lee, Jae‐Hwan Jeong, I. Lee, Jeeyeon Lee, J. Jung, H. Park, D. Lee, Y. Chae (2019)
Effect of High-dose Vitamin C Combined With Anti-cancer Treatment on Breast Cancer CellsAntiCancer Research, 39
Ngoc Nguyen, Ngoc Nguyen, Ngo Tran, P. Le, Thi Nguyen, Ngoc Nguyen, L. Bach, Vu Doan, H. Tran, Van Le, N. Tran (2018)
Synergic Activity Against MCF-7 Breast Cancer Cell Growth of Nanocurcumin-Encapsulated and Cisplatin-Complexed NanogelsMolecules, 23
N. Bijker, J. Peterse, L. Duchateau, J. Julien, I. Fentiman, C. Duval, S. Palma, J. Simony‐Lafontaine, I. Mascarel, M. Vijver (2001)
Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 19 8
A. Batool, R. Arshad, Sobia Razzaq, Kainat Nousheen, M. Kiani, G. Shahnaz (2020)
Formulation and evaluation of hyaluronic acid-based mucoadhesive self nanoemulsifying drug delivery system (SNEDDS) of tamoxifen for targeting breast cancer.International journal of biological macromolecules
Li Li, Xinlan Xu, L. Fang, Yu Liu, Yinghua Sun, Man Wang, Nanxi Zhao, Zhonggui He (2010)
The Transdermal Patches for Site-Specific Delivery of Letrozole: A New Option for Breast Cancer TherapyAAPS PharmSciTech, 11
Y. Yu, Qun Zhou, Y. Hang, X. Bu, W. Jia (2007)
Antiestrogenic effect of 20S‐protopanaxadiol and its synergy with tamoxifen on breast cancer cellsCancer, 109
M. Gail, J. Costantino, J. Bryant, R. Croyle, L. Freedman, K. Helzlsouer, V. Vogel (1999)
Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer.Journal of the National Cancer Institute, 91 21
S. Singh, Shriti Singh, J. Lillard, Rajesh Singh (2017)
Drug delivery approaches for breast cancerInternational Journal of Nanomedicine, 12
P. Munekata, M. Pateiro, F. Barba, R. Domínguez, M. Gagaoua, J. Lorenzo (2020)
Development of new food and pharmaceutical products: Nutraceuticals and food additives.Advances in food and nutrition research, 92
Atefeh Yassemi, S. Kashanian, H. Zhaleh (2020)
Folic acid receptor-targeted solid lipid nanoparticles to enhance cytotoxicity of letrozole through induction of caspase-3 dependent-apoptosis for breast cancer treatmentPharmaceutical Development and Technology, 25
V. Jordan (2007)
Chemoprevention of breast cancer with selective oestrogen-receptor modulatorsNature Reviews Cancer, 7
Usha Sundralingam, Saravanan Muniyandy, A. Radhakrishnan, U. Palanisamy (2020)
Ratite oils for local transdermal therapy of 4-OH tamoxifen: development, characterization, and ex vivo evaluationJournal of Liposome Research, 31
Ommoleila Molavi, F. Narimani, Farshid Asiaee, Simin Sharifi, Vahideh Tarhriz, A. Shayanfar, M. Hejazi, R. Lai (2016)
Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapyPharmaceutical Biology, 55
J. Meng, Fangqin Guo, Haiyan Xu, Wei Liang, Chen Wang, Xian-da Yang (2016)
Combination Therapy using Co-encapsulated Resveratrol and Paclitaxel in Liposomes for Drug Resistance Reversal in Breast Cancer Cells in vivoScientific Reports, 6
M. Sheibani, Yaser Azizi, M. Shayan, S. Nezamoleslami, Faeze Eslami, M. Farjoo, A. Dehpour (2022)
Doxorubicin-Induced Cardiotoxicity: An Overview on Pre-clinical Therapeutic ApproachesCardiovascular Toxicology, 22
Santosh Bashyal, Gyubin Noh, Taekwang Keum, Y. Choi, Sangkil Lee (2016)
Cell penetrating peptides as an innovative approach for drug delivery; then, present and the futureJournal of Pharmaceutical Investigation, 46
S. Jayaraman, J. Reid, J. Hawse, M. Goetz (2021)
Endoxifen, an Estrogen Receptor Targeted Therapy: from Bench to Bedside.Endocrinology
Rifki Febriansah, Dyaningtyas Putri, Sarmoko, N. Nurulita, E. Meiyanto, A. Nugroho (2014)
Hesperidin as a preventive resistance agent in MCF-7 breast cancer cells line resistance to doxorubicin.Asian Pacific journal of tropical biomedicine, 4 3
R. Holland, J. Stekhoven, J. Hendriks, A. Verbeek, M. Mravunac (1990)
Extent, distribution, and mammographic/ histological correlations of breast ductal carcinoma in situThe Lancet, 335
N. Pondé, Lieveke Amaye, M. Lambertini, M. Paesmans, M. Piccart, E. Azambuja (2020)
Trastuzumab emtansine (T-DM1)-associated cardiotoxicity: Pooled analysis in advanced HER2-positive breast cancer.European journal of cancer, 126
H. Welch, S. Woloshin, Lisa Schwartz (2008)
The sea of uncertainty surrounding ductal carcinoma in situ--the price of screening mammography.Journal of the National Cancer Institute, 100 4
J. Thigpen (2012)
Adjuvant Tamoxifen Reduces Subsequent Breast Cancer in Women With Estrogen Receptor–Positive Ductal Carcinoma in Situ: A Study Based on NSABP Protocol B-24Yearbook of Medicine, 2012
V. Stearns, Tsuyoshi Mori, L. Jacobs, N. Khouri, E. Gabrielson, Takahiro Yoshida, S. Kominsky, D. Huso, S. Jeter, P. Powers, Karineh Tarpinian, Regina Brown, J. Lange, M. Rudek, Zhe Zhang, T. Tsangaris, S. Sukumar (2011)
Preclinical and Clinical Evaluation of Intraductally Administered Agents in Early Breast CancerScience Translational Medicine, 3
in-situ-treat ment-and-progn osis? search= carci nomai nsitu treat ment& source= search_ resul t& selec tedTi tle= 1~150&
Nusrat Chowdhury, I. Vhora, Ketan Patel, A. Bagde, S. Kutlehria, Mandip Singh (2018)
Development of Hot Melt Extruded Solid Dispersion of Tamoxifen Citrate and Resveratrol for Synergistic Effects on Breast Cancer CellsAAPS PharmSciTech, 19
Mengbing Chen, M. Shamim, A. Shahid, S. Yeung, B. Andresen, Jeffrey Wang, V. Nekkanti, F. Meyskens, K. Kelly, Ying Huang (2020)
Topical Delivery of Carvedilol Loaded Nano-Transfersomes for Skin Cancer ChemopreventionPharmaceutics, 12
M. Morales-Conde, Natividad López-Ibáñez, J. Calvete-Candenas, F. Mendonça (2019)
Fulvestrant-induced toxic epidermal necrolysis*Anais Brasileiros de Dermatologia, 94
(2014)
Breast Cancer Death Rate By Country
H. Kuerer, A. Buzdar, E. Mittendorf, F. Esteva, A. Lucci, L. Vence, L. Radvanyi, F. Meric-Bernstam, K. Hunt, W. Symmans (2011)
Biologic and immunologic effects of preoperative trastuzumab for ductal carcinoma in situ of the breastCancer, 117
A. Ackerman, Galen Kessler, T. Gyorfi, H. Tsou, G. Gottlieb (2007)
Contrary View: The Breast is not an Organ Per Se, but a Distinctive Region of Skin and Subcutaneous TissueThe American Journal of Dermatopathology, 29
T. Yen, K. Hunt, N. Mirza, E. Thomas, S. Singletary, G. Babiera, F. Meric-Bernstam, T. Buchholz, B. Feig, M. Ross, F. Ames, R. Theriault, H. Kuerer (2004)
Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situCancer, 100
Xian Li, Beibei Gao, X. Su (2020)
Anticancer bioactive peptide combined with docetaxel and its mechanism in the treatment of breast cancerExperimental and Therapeutic Medicine, 20
Manisha Pandey, Pung Wen, Giam Ning, Gan Xing, Liu Wei, D. Kumar, Jayashree Mayuren, Mayuren Candasamy, B. Gorain, Neha Jain, G. Gupta, K. Dua (2023)
Intraductal delivery of nanocarriers for ductal carcinoma in situ treatment: a strategy to enhance localized delivery.Nanomedicine
Nlp Barnes, JL Ooi, John Yarnold, N. Bundred (2012)
Ductal Carcinoma in Situ (DCIS) of the breastBMJ
P. Rouanet, G. Linares‐Cruz, F. Dravet, S. Poujol, S. Gourgou, J. Simony‐Lafontaine, J. Grenier, A. Kramar, J. Girault, E. Nestour, T. Maudelonde (2005)
Neoadjuvant percutaneous 4-hydroxytamoxifen decreases breast tumoral cell proliferation: a prospective controlled randomized study comparing three doses of 4-hydroxytamoxifen gel to oral tamoxifen.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23 13
Kah Yap, M. Sekar, Y. Wu, S. Gan, Nur Rani, L. Seow, V. Subramaniyan, N. Fuloria, S. Fuloria, Pei Lum (2021)
Hesperidin and its aglycone hesperetin in breast cancer therapy: A review of recent developments and future prospectsSaudi Journal of Biological Sciences, 28
H. Pujol, J. Girault, P. Rouanet, S. Fournier, J. Grenier, J. Simony, J. Fourtillan, J. Pujol (2004)
Phase I Study of percutaneous 4-hydroxy-tamoxifen with analyses of 4-hydroxy-tamoxifen concentrations in breast cancer and normal breast tissueCancer Chemotherapy and Pharmacology, 36
J. Groot, P. Diest, Miranda Amersfoort, E. Vlug, Xiaojuan Pan, N. Hoeve, H. Rosing, J. Beijnen, S. Youssef, A. Bruin, J. Jonkers, E. Wall, P. Derksen (2017)
Intraductal cisplatin treatment in a BRCA-associated breast cancer mouse model attenuates tumor development but leads to systemic tumors in aged female miceOncotarget, 8
Samiha Mohsen, P. Sobash, G. Algwaiz, Noor Nasef, Safaa Al-Zeidaneen, N. Karim (2022)
Autophagy Agents in Clinical Trials for Cancer Therapy: A Brief ReviewCurrent Oncology, 29
Alyssa Schlotman, Adam Stater, Kyle Schuler, J. Heideman, V. Abramson (2020)
Grade 3 Hepatotoxicity following Fulvestrant, Palbociclib, and Erdafitinib Therapy in a Patient with ER-Positive/PR-Negative/HER2-Negative Metastatic Breast Cancer: A Case ReportCase Reports in Oncology, 13
M. Joseph, MdSaiful Islam, J. Reineke, M. Hildreth, T. Woyengo, Angela Pillatzki, Aravind Baride, Omathanu Perumal (2019)
Intraductal Drug Delivery to the Breast: Effect of Particle size and Formulation on Breast Duct and Lymph Node Retention.Molecular pharmaceutics
H. Sinn, H. Kreipe (2013)
A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd EditionBreast Care, 8
Y. Choi, Eunmi Park (2015)
Ferulic acid in combination with PARP inhibitor sensitizes breast cancer cells as chemotherapeutic strategy.Biochemical and biophysical research communications, 458 3
DC Allred, SJ Anderson, S Paik, DL Wickerham, ID Nagtegaal, SM Swain (2012)
Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24J Clin Oncol, 30
G. Cevc, G. Blume, A. Schätzlein (1997)
Transfersomes-mediated transepidermal delivery improves the regio-specificity and biological activity of corticosteroids in vivoJournal of Controlled Release, 45
H. Wong, R. Bendayan, A. Rauth, Yongqiang Li, X. Wu (2007)
Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles.Advanced drug delivery reviews, 59 6
Abdelnaser Badawy, Rashad Othman, M. El-Magd (2021)
Effect of combined therapy with camel milk-derived exosomes, tamoxifen, and hesperidin on breast cancerMolecular & Cellular Toxicology
G. Salata, Isabella Malagó, L. Lopes (2022)
A Lipid-Based In Situ-Forming Hexagonal Phase for Prolonged Retention and Drug Release in the Breast TissueAAPS PharmSciTech, 23
Y. Zhan, Yinnan Chen, Rui Liu, Han Zhang, Yanmin Zhang (2013)
Potentiation of paclitaxel activity by curcumin in human breast cancer cell by modulating apoptosis and inhibiting EGFR signalingArchives of Pharmacal Research, 37
A. Dubey, R. Shriram, S. El-Zahaby (2021)
A review on exploring better safety prospects in managing cancer using liposomal combinations of food bioactive compounds and anticancer drugs: Combisomes.Current drug delivery
G. Mannu, Zhe Wang, J. Broggio, J. Charman, S. Cheung, O. Kearins, D. Dodwell, S. Darby (2020)
Invasive breast cancer and breast cancer mortality after ductal carcinoma in situ in women attending for breast screening in England, 1988-2014: population based observational cohort studyThe BMJ, 369
(2008)
Doxorubicin hydrochloride liposome in treating women with ductal carcinoma in situ undergoing surgery
Zichao Gu, Firas Al-Zubaydi, Derek Adler, Shike Li, Steven Johnson, Puja Prasad, Jennifer Holloway, Z. Székely, S. Love, Dayuan Gao, P. Sinko (2018)
Evaluation of intraductal delivery of poly(ethylene glycol)‐doxorubicin conjugate nanocarriers for the treatment of ductal carcinoma in situ (DCIS)‐like lesions in ratsJournal of Interdisciplinary Nanomedicine, 3
Bexarotene in preventing breast cancer in patients at high risk for breast cancer -full text view -ClinicalTrials.gov
Kaushalkumar Dave, R. Averineni, Preety Sahdev, Omathanu Perumal (2014)
Transpapillary Drug Delivery to the BreastPLoS ONE, 9
Ductal carcinoma in situ (DCIS) is currently treated through breast-conserving surgery (lumpectomy), radiation therapy, breast-removing surgery (mastectomy), and hormone therapy to prevent further progression into invasive breast cancer and recurrence. Discrepancies concerning the prognosis of DCIS have sparked controversy about adequate treatment. Considering the severe medical and psychological consequences of mastectomy, developing a treatment approach that arrests the progression of DCIS to the invasive stage without affecting the non-cancerous cells is of utmost importance. In the current review, the problems associated with the diagnosis and management of DCIS have been thoroughly discussed. A summary of the route of administration and drug delivery systems to manage DCIS was also provoked. Innovative ultra-flexible combisomes were also proposed for the effective management of DCIS. Prevention is essential in managing the risk of DCIS and reducing the risk of progression to invasive breast cancer. While prevention is vital, it is not always possible to prevent DCIS, and in some cases, treatment may be necessary. Hence, this review recommends that ultra-flexible combisomes administered as a topical gel provide a non-systemic approach for managing DCIS and thus significantly minimize the side effects and costs associated with existing therapies.Graphical Abstract[graphic not available: see fulltext]
AAPS PharmSciTech – Springer Journals
Published: May 12, 2023
Keywords: ductal carcinoma in situ; non-systemic; topical; ultra-flexible combisomes
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.